Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bannister

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
The British Journal of Clinical Practice|August 1, 1990
Which respiratory anti-infective agent?B Bannister
Journal of the Royal College of Physicians of London|January 1, 1996
Infectious diseases: who cares and how much?B Bannister
The Dental Register|March 11, 2021
Repointing and Manufacturing InstrumentsB Bannister
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
Modifications of lincomycin involving the carbohydrate portion. I. The 2-O-methyl and 2-deoxy-analoguesB Bannister
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
Modifications of lincomycin involving the carbohydrate portion. II. Analogues with D-gluco- and D-ido-stereochemistryB Bannister
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1974
Modifications of lincomycin involving the carbohydrate portion. IV. (7S)-7-alkoxy-7-deoxy-analoguesB Bannister
The Journal of Antibiotics|July 1, 1972
The synthesis and biological activities of some analogs of streptozotocinB Bannister
BMJ (Clinical Research Ed.)|January 12, 1991
Lassa feverB Bannister
Communicable Disease and Public Health|January 8, 2004
Malaria 2003: the malaria parasite is still evolving, but so are the options for prophylaxisB Bannister
Communicable Disease and Public Health|August 30, 2001
New guidelines on malaria preventionB Bannister
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
The British Journal of Clinical Practice|August 1, 1990
Which respiratory anti-infective agent?B Bannister
Journal of the Royal College of Physicians of London|January 1, 1996
Infectious diseases: who cares and how much?B Bannister
The Dental Register|March 11, 2021
Repointing and Manufacturing InstrumentsB Bannister
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
Modifications of lincomycin involving the carbohydrate portion. I. The 2-O-methyl and 2-deoxy-analoguesB Bannister
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
Modifications of lincomycin involving the carbohydrate portion. II. Analogues with D-gluco- and D-ido-stereochemistryB Bannister
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1974
Modifications of lincomycin involving the carbohydrate portion. IV. (7S)-7-alkoxy-7-deoxy-analoguesB Bannister
The Journal of Antibiotics|July 1, 1972
The synthesis and biological activities of some analogs of streptozotocinB Bannister
BMJ (Clinical Research Ed.)|January 12, 1991
Lassa feverB Bannister
Communicable Disease and Public Health|January 8, 2004
Malaria 2003: the malaria parasite is still evolving, but so are the options for prophylaxisB Bannister
Communicable Disease and Public Health|August 30, 2001
New guidelines on malaria preventionB Bannister
Pageof 6